Published in Cancer Weekly, July 17th, 2001
Ninety percent of patients in the study experienced reconstitution of blood cells (hematopoeisis) and the incidence of graft-versus-host disease was low despite genetic mismatching of donors and recipients. Further, 19 of the study's very high risk patients (26%) were alive and 18 patients disease-free 40 months after transplantation. The study appeared in the June 14, 2001, New England Journal of Medicine.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.